Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic ShockPierre‐François Laterre, Roger Lewis, Steven M. Opal et al.|JAMA|2019Cited by 141
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)Yasser Sakr, Jean‐Louis Vincent, Jean‐Yves Lefrant et al.|Intensive Care Medicine|2018Cited by 138
Worldwide audit of blood transfusion practice in critically ill patientsYasser Sakr, Jean‐Louis Vincent, Ulrich Jaschinski et al.|Critical Care|2018Cited by 130
Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage studyÉtienne Gayat, Alexandre Mebazaa, Matthieu Resche‐Rigon et al.|Intensive Care Medicine|2011Cited by 121
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Thorbjørn Grøfte, Simon Lambden et al.|The Lancet Respiratory Medicine|2023Cited by 76